Early versus delayed treatment with glatiramer acetate: Analysis of up to 27 years of continuous follow-up in a US open-label extension study. - Ford CC; Cohen JA; Goodman AD; Lindsey JW; Lisak RP; Luzzio C; Pruitt A; Rose J; Rus H; Wolinsky JS; Kadosh SE; Bernstein-Hanlon E; et al. (Multiple sclerosis (Houndmills, Basingstoke, England), 2022)